RxDoctor Payments Data

Ross Krasnow, MD

Urology · Washington, DCNPI 1437471992

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,473 of the $1,695 with a category attached, or 86.9%. It is spread thinly across 21 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in DC, where the typical reported total is $1,957.

$1,695in general payments, 2019–2025

Across 29 payments — averaging $58.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$388
  • Agiliti Surgical, Inc.$232
  • Johnson & Johnson$157
  • Photocure Inc$155
  • Ferring Pharmaceuticals Inc.$118
  • Immunitybio, Inc.$102
  • plus $544 from 15 others

What the payments were for

  • Travel & lodging$22313%
  • Food & beverage$1,47387%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,695 in reported general payments places this provider in the 45th percentile of 47 urology providers in District of Columbia.

See all urology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$205,595
Medicare patients
502
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron21$11,852
Solifenacin Succinate58$3,056
Tamsulosin Hcl132$2,219
Tadalafil23$1,374
Finasteride62$624
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$93

Paid to pharmacies, not to this prescriber.

Other urology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →